Revenue from operations came at Rs. 609 Cr (36.7% QoQ, 94.9% YoY) vs QoQ Rs. 445.5 Cr, YoY Rs. 312.4 Cr
Higher Revenue is on account of upper shre of EPC revenue wherever company is implementing Asian country web clinical trial project
EBIDTA came at Rs. 119.7 Cr (12.2% QoQ, 40.5% YoY) vs QoQ Rs. 106.7 Cr, YoY Rs. 85.2 Cr.
Avail more stock tips from our Experts.
EBITDA Margin came at nineteen.7% vs QoQ pure gold, YoY 27.3%
Lower Earnings Before Interest Taxes Depreciation and Amortization margin is on account of lower margin in EPC project
Adj. PAT came at Rs. 28.9 metallic element vs QoQ Rs. 29.4 Cr, YoY Rs. 14.6 Cr
Quarter EPS is Rs. 2.6
Share is mercantilism at P/E of eight.1x FY20E EPS
For free stock tips visit our website.
No comments:
Post a Comment